Illumina stock holds near its yearly high as targets diverge

Published on 09/22/2026 at 12:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Illumina stock traded at USD 238.46 on September 22, 2026, below its USD 245.20 yearly high. Evercore raised its target to USD 200 from USD 155.

Schwarzweiß-Reportagefoto einer Wissenschaftlerin beim Pipettieren im Genomiklabor — Illumina Inc. zeigt US4523271090 in dokumentarischer Schwarzweiß-Reportage einer Wissenschaftlerin beim Pipettieren im Labor, Illustration mit AI erstellt.

Illumina Inc. (ISIN US4523271090) traded at USD 238.46 on Nasdaq on September 22, 2026, down 0.48 percent, leaving the shares below the 52-week high of USD 245.20 and well above the 52-week low of USD 91.00. The latest analyst updates show a wide valuation gap, with Evercore ISI raising its target to USD 200 from USD 155 while Barclays lifted its target to USD 145 from USD 122.

Analyst targets remain below price

According to ScanX on September 21, 2026, Evercore ISI analyst Vijay Kumar maintained an Outperform rating and raised the price target from USD 155 to USD 200. The same report listed Piper Sandler and Guggenheim at USD 200, while Bernstein held a Market Perform rating with a USD 185 target.

The valuation signal is mixed rather than uniform. ScanX also reported on September 21, 2026, that Barclays retained an Underweight rating while increasing its target from USD 122 to USD 145. Both revised targets remained below the quoted Nasdaq price of USD 238.46.

Market value stays elevated

Pluang data dated September 22, 2026, placed Illumina's market capitalization at USD 36.18 billion and its 52-week range at USD 91.00 to USD 245.20. The quoted price was only USD 6.74, or 2.75 percent, below the yearly high, while the daily decline was 0.48 percent.

The latest available operating context in the supplied market data shows trailing twelve-month revenue of USD 4.37 billion and diluted trailing twelve-month earnings per share of negative USD 7.69, both labeled as trailing measures rather than a newly reported quarter. That distinction matters because the current share price is close to the annual high even as the reported trailing EPS remains negative.

Price remains near yearly high

Illumina stock closed at USD 238.46 on Nasdaq on September 22, 2026, with a daily change of negative 0.48 percent. The combination of a USD 36.18 billion market capitalization, a USD 245.20 52-week high and analyst targets between USD 145 and USD 200 gives the current quotation a clearly higher level than the cited target range.